Search results
3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole
Motley Fool via Yahoo Finance· 1 week agoThat doesn't seem likely. It has just one program in its pipeline, a combination vaccine against the...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 4 days agovaccine in partnership with Merck. The shot prompts an immune response against a patient's own tumor...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 5 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...